| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173181A Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 02/11/1998 | CN1173179A Substituted 2 -(phosphinyloxymethyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173178A Imidazo £ 4, 5-c| quinoleine amines |
| 02/11/1998 | CN1173177A 6 -methoxy -1 H -benzotriazole -5 -carboxamide derivatives, process for producing the same, and medicinal composition contaning the same |
| 02/11/1998 | CN1173176A 2 -substituted 1, 2, 5 -thiadiazolidin-3 -one 1, 1-dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173175A Substituted 2 -arylcaronyloxymethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1-dioxide derivatives and compositions and method of use thereof |
| 02/11/1998 | CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors |
| 02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
| 02/11/1998 | CN1173135A Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 02/11/1998 | CN1173134A Use of incense in the treatment of alzheimer's disease |
| 02/11/1998 | CN1173133A Phosphate-binding polymers for oral administration |
| 02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
| 02/11/1998 | CN1173131A 2 -(2, 3, 5, 6 -tetrafluoro -4 -phridyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173130A 2 -heterocyclyloxy and thiomethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof |
| 02/11/1998 | CN1173129A Anti-inflammatory eyecrops |
| 02/11/1998 | CN1173128A Polynucleotide compositions |
| 02/11/1998 | CN1172807A Neuraminic acid derivatives, their preparation and their medical use |
| 02/11/1998 | CN1172803A Bicyclic-fused pyridines |
| 02/11/1998 | CN1172802A Process for preparation of £(5, 6 -dicarboxy 3 -pyridyl) methyl| ammonium halides |
| 02/11/1998 | CN1172801A Fluorinated vitamin D3 analogs |
| 02/11/1998 | CN1172793A 1, 25 -dihydroxy -16, 22, 23 -trisdehydro-chdecalciferol derivatives |
| 02/11/1998 | CN1172649A Hair regrowth liniment and its preparation method |
| 02/11/1998 | CN1172646A Fill material for soft gelatin pharmaceutical dosage form containing antiflatulent |
| 02/11/1998 | CN1172645A Citrate lithodialyzate and its preparation method |
| 02/11/1998 | CN1172644A Agent for prophylaxis and treatment of disturbance of visual function |
| 02/11/1998 | CN1172643A Preparation of salts of pharmaceutical active substances which have acidic groups |
| 02/11/1998 | CN1172642A Multiphase soft gelatin dosage form |
| 02/11/1998 | CN1172591A Dietetic foods and pharmaceutical preparations inhibiting blood coagulation |
| 02/11/1998 | CN1037348C Method for preparing substituted 5 -(2 -(2 -(2 -aryl -2 hydroxyethyl) amino) propyl -1, 3 -benzodioxoles amylene |
| 02/11/1998 | CN1037347C Method for preparation polytehoxylated vitamin E |
| 02/10/1998 | US5717113 Antitumor agents |
| 02/10/1998 | US5717102 Psychotherapeutics; headaches |
| 02/10/1998 | US5717099 Method of synthesis for 6,9-bis((2-aminoethyl)amino)benzo g!isoquinoline-5,10-dione and its dimaleate salt |
| 02/10/1998 | US5717093 Difluoro statone analogs |
| 02/10/1998 | US5717092 Compounds with improved multi-drug resistance activity |
| 02/10/1998 | US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy |
| 02/10/1998 | US5717083 Phosphoramidate and phosphorothiomidate oligomeric compounds |
| 02/10/1998 | US5717063 Veterinary medicine; nematodes |
| 02/10/1998 | US5716995 Anti-osteopathic composition |
| 02/10/1998 | US5716994 Plant extracts |
| 02/10/1998 | US5716993 Anthranilic acid derivatives |
| 02/10/1998 | US5716992 Topical applying to human skin |
| 02/10/1998 | US5716991 Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
| 02/10/1998 | US5716989 Bicyclo 3.3.0!octane derivatives, process for their production and their pharmaceutical use |
| 02/10/1998 | US5716988 Ready-to-use; parenteral administering |
| 02/10/1998 | US5716987 Topically or transdermally administering phenoxyacetic acid and/or its lower alkyl ester |
| 02/10/1998 | US5716986 Lipoxygenase inhibitors |
| 02/10/1998 | US5716983 Use of coumarins and carbostyrils as PLA2 inhibitors, new coumarins and carbostyrils, processes for the production thereof and pharmaceutical agents |
| 02/10/1998 | US5716982 Retinoids and methods of use of same |
| 02/10/1998 | US5716981 A stent coated with paclitaxel, a taxan derivative and a polymeric carrier; medical equipment for deblocking |
| 02/10/1998 | US5716980 Alcohol or aldehyde derivatives and their use |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716978 Methods of treating circadian rhythm disorders |
| 02/10/1998 | US5716976 Administering anorexients |
| 02/10/1998 | US5716975 Nontoxic rhodanine derivatives; antidiabetic agents, cathepsin d inhibitors, b-amyloid protein reduction |
| 02/10/1998 | US5716974 Heterobicyclic compounds with fungicidal activity |
| 02/10/1998 | US5716973 Anti-viral compounds |
| 02/10/1998 | US5716970 Diuretic compound |
| 02/10/1998 | US5716967 Isoxazoline compounds as antiinflammatory agents |
| 02/10/1998 | US5716966 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 02/10/1998 | US5716963 Diazaquinomycin derivative |
| 02/10/1998 | US5716962 Treating hyperglycemia and hyperinsulinemia |
| 02/10/1998 | US5716961 Treatment of tinnitus using neuroprotective agents |
| 02/10/1998 | US5716960 Crystalline trimetrexate salts and the process for making the same |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning |
| 02/10/1998 | US5716956 Dihydrophthalazine antagonists of excitatory amino acid receptors |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716953 Modifiers of gastrin and cholecystokinins |
| 02/10/1998 | US5716952 Topical application |
| 02/10/1998 | US5716951 Tricyclic inhibitors of the vitronectin receptor |
| 02/10/1998 | US5716949 Heterocyclic compounds |
| 02/10/1998 | US5716948 3-substituted carbacephems |
| 02/10/1998 | US5716947 Topical doxyl composition and method |
| 02/10/1998 | US5716946 Multiple sclerosis treatment |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716943 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 02/10/1998 | US5716942 Treatment of migraine with morpholine tachykinin receptor antagonists |
| 02/10/1998 | US5716941 Treating mammals with a demyelinating disease associated with an immunological disorder comprising administering methylcobalamine or cyanocobalamin |
| 02/10/1998 | US5716939 Amide derivatives of 16-membered ring antibiotic macrolides |
| 02/10/1998 | US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 02/10/1998 | US5716933 Adjustment the prolactin and glucoccorticosteroid ratio in blood |
| 02/10/1998 | US5716932 Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates |
| 02/10/1998 | US5716931 Administering lantibiotic by aerosol |
| 02/10/1998 | US5716929 Inhibitors of interleukin-1β converting enzyme |
| 02/10/1998 | US5716928 Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| 02/10/1998 | US5716926 Enhancing the physical endurance of mammal by administering to mammal the anabolic protein and pyruvate |
| 02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
| 02/10/1998 | US5716793 Immunocomplexing |
| 02/10/1998 | US5716777 Regulation of meiosis using sterols |
| 02/10/1998 | US5716648 Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
| 02/10/1998 | US5716641 Simethicone containing pharmaceutical compositions |
| 02/10/1998 | US5716636 Transdermal therapeutic system with acetylsalicylic acid in crystalline form as active substance |
| 02/10/1998 | US5716634 Clear, homogenized, flowable hydrogel of crosslinked N-vinyl lactam polymer |
| 02/10/1998 | US5716632 Administering n-substituted 2-(1h)pyridones or 3-(1h)pyridones |
| 02/10/1998 | US5716631 Solubilized within polymer matrix |
| 02/10/1998 | US5716625 Formulations and methods for reducing skin irritation |
| 02/10/1998 | US5716624 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 02/10/1998 | US5716612 Desensitizing the cancer cell drug resistance |